{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:16Z","timestamp":1786997896981,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.vaccine.2008.09.052","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T14:19:12Z","timestamp":1223734752000},"page":"6975-6979","source":"Crossref","is-referenced-by-count":36,"title":["Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands"],"prefix":"10.1016","volume":"26","author":[{"given":"A.","family":"Meerveld-Eggink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"de Weerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.T.","family":"Rijkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"van Velzen-Blad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.H.","family":"Biesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2008.09.052_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/jcp.54.3.214","article-title":"Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed","volume":"54","author":"Waghorn","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.vaccine.2008.09.052_bib2","unstructured":"Centers for Disease control and prevention. Recommended Adult Immunization Schedule \u2013 United States, October 2007 \u2013 September 2008. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR QuickGuide 2007;56(41):Q1\u2013Q4."},{"key":"10.1016\/j.vaccine.2008.09.052_bib3","doi-asserted-by":"crossref","unstructured":"Working party of the British Committee for Standards in Haematology. Clinical Haematology Task Force. Guidelines for the prevention and treatment on infection in patients with an absent or dysfunctional spleen. BMJ 1996;312:430\u2013434.","DOI":"10.1136\/bmj.312.7028.430"},{"key":"10.1016\/j.vaccine.2008.09.052_bib4","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(00)05227-2","article-title":"Prevention of overwhelming sepsis in asplenic patients: could do better","volume":"357","author":"Spelman","year":"2001","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2008.09.052_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bmj.331.7514.417","article-title":"Preventing severe infection after splenectomy","volume":"331","author":"Newland","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2008.09.052_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/IAI.45.1.248-254.1984","article-title":"Preparation of human hyperimmune globulin to Haemophilus influenza b, Streptococcus pneumoniae, and Neisseria meningitidis","volume":"45","author":"Siber","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.052_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/infdis\/166.3.632","article-title":"Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood","volume":"166","author":"Goldblatt","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.052_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-1759(92)90163-N","article-title":"Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology","volume":"148","author":"Herrmann","year":"1992","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.052_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0022-1759(93)90270-H","article-title":"A modified enzyme-linked immunosorbent assay for measuring type-specific antipneumococcal capsular polysaccharide antibodies","volume":"164","author":"Konradsen","year":"1993","journal-title":"J Immunol Methods"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.052_bib10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/CDLI.10.4.514-519.2003","article-title":"Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides","volume":"10","author":"Wernette","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2008.09.052_bib11","unstructured":"World Health Organization. Pneumococcal conjugate vaccines Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Tech Rep Ser 927; Annex 2; 2005, p. 64\u201398."},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.052_bib12","first-page":"1","article-title":"Anti-capsular polysaccharide antibody deficiency states","volume":"5","author":"Rijkers","year":"1993","journal-title":"Immunodeficiency"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.052_bib13","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus Influenzae type b","volume":"147","author":"K\u00e4yhty","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.052_bib14","unstructured":"Centers for disease control and prevention. Prevention and control of Meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2005;54:1\u201321."},{"key":"10.1016\/j.vaccine.2008.09.052_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7861\/clinmedicine.2-5-440","article-title":"Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen","volume":"2","author":"Davies","year":"2002","journal-title":"Clin Med JRPCL"},{"key":"10.1016\/j.vaccine.2008.09.052_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2249.1992.tb06956.x","article-title":"The spleen? Who needs it anyway? Editorial Review","volume":"89","author":"Hazlewoord","year":"1992","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.052_bib17","first-page":"45","article-title":"Prevention of infections in hyposplenic and asplenic patients: an update","volume":"62","author":"Melles","year":"2004","journal-title":"Neth J Med"},{"key":"10.1016\/j.vaccine.2008.09.052_bib18","unstructured":"Recommendations of the Immunization Practices Advisory Committee (ACIP) Update: Pneumococcal Polysaccharide Vaccine Usage\u2014United States. MMWR 1984;33(20):273\u2013276,281."},{"key":"10.1016\/j.vaccine.2008.09.052_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jcp.52.6.424","article-title":"Northern region asplenia register\u2014analysis of first two years","volume":"52","author":"Spickett","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.vaccine.2008.09.052_bib20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0196-6553(98)70038-0","article-title":"Pneumococcal vaccine administration associated with splenectomy: missed opportunities","volume":"26","author":"Kind","year":"1998","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2008.09.052_bib21","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/bmj.307.6916.1398","article-title":"Pneumococcal vaccination after splenectomy: survey of hospital and primary care records","volume":"307","author":"Kinnersley","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2008.09.052_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1096-8652(200009)65:1<25::AID-AJH4>3.0.CO;2-8","article-title":"Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist","volume":"65","author":"Brigden","year":"2000","journal-title":"Am J Hematol"},{"issue":"8224","key":"10.1016\/j.vaccine.2008.09.052_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(81)92681-7","article-title":"Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine","volume":"1","author":"Hosea","year":"1981","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2008.09.052_bib24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2005.05918.x","article-title":"Immunogenicity of sequential pneumococcal vaccination in subjects splenectomized for hereditary spherocytosis","volume":"132","author":"Stoehr","year":"2005","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.09.052_bib25","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1128\/IAI.69.12.7583-7587.2001","article-title":"Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides","volume":"69","author":"Breukels","year":"2001","journal-title":"Infect Immunity"},{"key":"10.1016\/j.vaccine.2008.09.052_bib26","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1086\/428135","article-title":"Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine","volume":"191","author":"Musher","year":"2005","journal-title":"JID"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08013108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08013108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T23:16:11Z","timestamp":1588979771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08013108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":26,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0264410X08013108"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}